Glutamate receptor genes (original) (raw)

• Cooper B. (2001) Nature, nurture and mental disorder: old concepts in the new millennium. Br. J. Psychiatry Suppl. 40, S91–101.
  PubMed CAS Google Scholar
• Manji H. K., Drevets W. C., and Charney D. S. (2001) The cellular neurobiology of depression. Nat. Med. 7, 541–547.
  PubMed CAS Google Scholar
• Lewis D. A. and Lieberman J. A. (2000) Catching up on schizophrenia: natural history and neurobiology. Neuron 28, 325–334.
  PubMed CAS Google Scholar
• Olney J. W., Newcomer J. W., and Farber N. B. (1999) NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 33, 523–533.
  PubMed CAS Google Scholar
• Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., and Carlsson M. L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol. 41, 237–260.
  PubMed CAS Google Scholar
• Hollmann M. and Heinemann S. (1994) Cloned glutamate receptors. Annu. Rev. Neurosci. 17, 31–108.
  PubMed CAS Google Scholar
• Nakanishi S., Nakajima Y., Masu M., Ueda Y., Nakahara K., Watanabe D., et al. (1998) Glutamate receptors: brain function and signal transduction. Brain Res. Brain Res. Rev. 26, 230–235.
  PubMed Google Scholar
• Dingledine R., Borges K., Bowie D., and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7–61.
  PubMed CAS Google Scholar
• Lerma J., Paternain A. V., Rodriguez-Moreno A., and Lopez-Garcia J. C. (2001) Molecular physiology of kainate receptors. Physiol. Rev. 81, 971–998.
  PubMed CAS Google Scholar
• Skerry T. M. and Genever P. G. (2001) Glutamate signalling in non-neuronal tissues. Trends Pharmacol. Sci. 22, 174–181.
  PubMed CAS Google Scholar
• Scannevin R. H. and Huganir R. L. (2000) Postsynaptic organization and regulation of excitatory synapses. Nat. Rev. Neurosci. 1, 133–141.
  PubMed CAS Google Scholar
• Hollmann M., Maron C., and Heinemann S. (1994) N-glycosylation site tagging suggests a three transmembrane domain topology for the glutamate receptor GluR1. Neuron 13, 1331–1343.
  PubMed CAS Google Scholar
• VanDongen H. M. and VanDongen A. M. (1999) Determination of membrane topology of glutamate receptors. Methods Mol. Biol. 128, 155–166.
  PubMed CAS Google Scholar
• Verdoorn T. A., Burnashev N., Monyer H., Seeburg P. H., and Sakmann B. (1991) Structural determinants of ion flow through recombinant glutamate receptor channels. Science 252, 1715–1718.
  PubMed CAS Google Scholar
• Hume R. I., Dingledine R., and Heinemann S. F. (1991) Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 253, 1028–1031.
  PubMed CAS Google Scholar
• Stern-Bach Y., Bettler B., Hartley M., Sheppard P. O., O’Hara P. J., and Heinemann S. F. (1994) Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron 13, 1345–1357.
  PubMed CAS Google Scholar
• Ferrer-Montiel A. V. and Montal M. (1996) Pentameric subunit stoichiometry of a neuronal glutamate receptor. Proc. Natl. Acad. Sci. USA 93, 2741–2744.
  PubMed CAS Google Scholar
• Rosenmund C., Stern-Bach Y., and Stevens C. F. (1998) The tetrameric structure of a glutamate receptor channel. Science 280, 1596–1599.
  PubMed CAS Google Scholar
• Kennedy M. B. (1997) The postsynaptic density at glutamatergic synapses. Trends Neurosci. 20, 264–268.
  PubMed CAS Google Scholar
• Sheng M. (2001) Molecular organization of the postsynaptic specialization. Proc. Natl. Acad. Sci. USA 98, 7058–7061.
  PubMed CAS Google Scholar
• Tomita S., Nicoll R. A., and Bredt D. S. (2001) PDZ protein interactions regulating glutamate receptor function and plasticity. J. Cell Biol. 153, F19–24.
  PubMed CAS Google Scholar
• Sattler R. and Tymianski M. (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78, 3–13.
  PubMed CAS Google Scholar
• McNamara J. O. (1993) Excitatory amino acid receptors and epilepsy. Curr. Opin. Neurol. Neurosurg. 6, 583–587.
  PubMed CAS Google Scholar
• Lee J. M., Zipfel G. J., and Choi D. W. (1999) The changing landscape of ischaemic brain injury mechanisms. Nature 399, A7–14.
  PubMed CAS Google Scholar
• Weiss J. H. and Sensi S. L. (2000) Ca2+-Zn2+permeable AMPA or kainate receptors: possible key factors in selective neurodegeneration. Trends Neurosci. 23, 365–371.
  PubMed CAS Google Scholar
• Zipfel G. J., Babcock D. J., Lee J. M., and Choi D. W. (2000) Neuronal apoptosis after CNS injury: the roles of glutamate and calcium. J. Neurotrauma 17, 857–869.
  PubMed CAS Google Scholar
• Seeburg P. H. (1996) The role of RNA editing in controlling glutamate receptor channel properties. J. Neurochem. 66, 1–5.
  PubMed CAS Google Scholar
• Maas S., Melcher T., and Seeburg P. H. (1997) Mammalian RNA-dependent deaminases and edited mRNAs. Curr. Opin. Cell Biol. 9, 343–349.
  PubMed CAS Google Scholar
• Higuchi M., Single F. N., Kohler M., Sommer B., Sprengel R., and Seeburg P. H. (1993) RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75, 1361–1370.
  PubMed CAS Google Scholar
• Sommer B., Kohler M., Sprengel R., and Seeburg P. H. (1991) RNA editing in brain controls a determinant of ion flow in glutamate- gated channels. Cell 67, 11–19.
  PubMed CAS Google Scholar
• Pellicciari R., Costantino G., and Macchiarulo A. (2000) Metabotropic glutamate receptors: a structural view point. Pharm. Acta. Helv. 74, 231–237.
  PubMed CAS Google Scholar
• Alagarsamy S., Sorensen S. D., and Conn P. J. (2001) Coordinate regulation of metabotropic glutamate receptors. Curr. Opin. Neurobiol. 11, 357–362.
  PubMed CAS Google Scholar
• Spooren W. P. J. M., Gasparini F., Salt T. E., and Kuhn R. (2001) Novel allosteric antagonists shed light on mGluR5 receptors and CNS disorders. Trends Pharmacol. Sci. 22, 331–337.
  PubMed CAS Google Scholar
• Seal R. P. and Amara S. G. (1999) Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39, 431–456.
  PubMed CAS Google Scholar
• DeFelice L. J. and Blakely R. D. (1996) Pore models for transporters? Biophys. J. 70, 579–580.
  PubMed CAS Google Scholar
• Gaal L., Roska B., Picaud S. A., Wu S. M., Marc R., and Werblin F. S. (1998) Postsynaptic response kinetics are controlled by a glutamate transporter at cone photoreceptors. J. Neurophysiol. 79, 190–196.
  PubMed CAS Google Scholar
• Masliah E., Alford M., DeTeresa R., Mallory M., and Hansen L. (1996) Deficient glutamate transport is associated with neurodegeneration in Alzheimer’s disease. Ann. Neurol. 40, 759–766.
  PubMed CAS Google Scholar
• Shaw P. J. (1999) Calcium, glutamate, and amyotrophic lateral sclerosis: more evidence but no certainties. Ann. Neurol. 46, 803–805.
  PubMed CAS Google Scholar
• Kim J. S., Kornhuber H. H., Schmid-Burgk W., and Holzmuller B. (1980) Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia. Neurosci. Lett. 20, 379–382.
  PubMed CAS Google Scholar
• Sharp F. R., Tomitaka M., Bernaudin M., and Tomitaka S. (2001) Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci. 24, 330–334.
  PubMed CAS Google Scholar
• Krystal J. H., D’Souza D. C., Petrakis I. L., Belger A., Berman R. M., Charney D. S., et al. (1999) NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders. Harv. Rev. Psychiatry 7, 125–143.
  PubMed CAS Google Scholar
• Krystal J. H., Karper L. P., Seibyl J. P., Freeman G. K., Delaney R., Bremner J. D., et al. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199–214.
  PubMed CAS Google Scholar
• Corssen G. and Domino E. F. (1966) Dissociative anesthesia: further pharmacologic studies and first clinical experience with the phencyclidine derivative CI-581. Anesth. Analg. 45, 29–40.
  PubMed CAS Google Scholar
• Domino E. F., Chodoff P., and Corssen G. (1965) Pharmacological effects of CI-581, a new dissociative anesthetic in man. Clin. Pharmacol. Ther. 6, 279–291.
  PubMed CAS Google Scholar
• Cohen B. D., Rosenbaum G., Luby E. D., and Gottlieb J. S. (1962) Comparison of phencyclidine hydrochloride (sernyl) with other drugs: simulation of schizophrenic performance with phencyclidine hydrochloride (sernyl)lysergic acid diethylamide (LSD-25), and amobarbital (Amytal)sodium: II. Symbolic and sequential thinking. Arch. Gen. Psychiatry 6, 79–85.
  Google Scholar
• Bakker C. B. and Amini F. B. (1961) Observations on the psychomimetic effects of sernyl. Compr. Psychiatry 2, 269–280.
  PubMed CAS Google Scholar
• Davies B. M. and Beech H. R. (1960) The effect of 1-arylcyclohexylamine (sernyl) on twelve normal volunteers. J. Ment. Sci. 106, 912–924.
  PubMed CAS Google Scholar
• Luby E. D., Cohen B. D., Rosenbaum G., Gottlieb J. S., and Kelley R. (1959) Study of a new schizophrenomimetic drug: Sernyl. Arch. Neurol. Psychiatry 81, 363–369.
  CAS Google Scholar
• Malhotra A. K., Pinals D. A., Adler C. M., Elman I., Clifton A., Pickar D., and Breier A. (1997) Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17, 141–150.
  PubMed CAS Google Scholar
• Javitt D. C. and Zukin S. R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry, 148, 1301–1308.
  PubMed CAS Google Scholar
• Cull-Candy S., Brickley S., and Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327–335.
  PubMed CAS Google Scholar
• Brauner-Osborne H., Egebjerg J., Nielsen E. O., Madsen U., and Krogsgaard-Larsen P. (2000) Ligands for glutamate receptors: design and therapeutic prospects. J. Med. Chem. 43, 2609–2645.
  PubMed CAS Google Scholar
• Noda A., Noda Y., Kamei H., Ichihara K., Mamiya T., Nagai T., et al. (2001) Phencyclidine impairs latent learning in mice: interaction between glutamatergic systems and sigma(1) receptors. Neuropsychopharmacology 24, 451–460.
  PubMed CAS Google Scholar
• Miyamoto Y., Yamada K., Noda Y., Mori H., Mishina M., and Nabeshima T. (2001) Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J. Neurosci. 21, 750–757.
  PubMed CAS Google Scholar
• Mohn A. R., Gainetdinov R. R., Caron M. G., and Koller B. H. (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98, 427–436.
  PubMed CAS Google Scholar
• Sams-Dodd F. F. (1996) Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmacol. 7, 3–23.
  PubMed CAS Google Scholar
• Handelmann G. E., Contreras P. C., and O’Donohue T. L. (1987) Selective memory impairment by phencyclidine in rats. Eur. J. Pharmacol. 140, 69–73.
  PubMed CAS Google Scholar
• Sturgeon R. D., Fessler R. G., and Meltzer H. Y. (1979) Behavioral rating scales for assessing phencyclidine-induced locomotor activity, stereotyped behavior and ataxia in rats. Eur. J. Pharmacol. 59, 169–179.
  PubMed CAS Google Scholar
• Schlemmer R. F., Jr., Jackson J. A., Preston K. L., Bederka J. P., Jr., Garver D. L., and Davis J. M. (1978) Phencyclidine-induced stereotyped behavior in monkeys: antagonism by pimozide. Eur. J. Pharmacol. 52, 379–384.
  PubMed CAS Google Scholar
• Moghaddam B. and Adams B. W. (1998) Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science 281, 1349–1352.
  PubMed CAS Google Scholar
• Corbett R., Camacho F., Woods A. T., Kerman L. L., Fishkin R. J., Brooks K., and Dunn R. W. (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology (Berl) 120, 67–74.
  CAS Google Scholar
• Carlsson M. and Carlsson A. (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia—implications for schizophrenia and Parkinson’s disease. Trends Neurosci. 13, 272–276.
  PubMed CAS Google Scholar
• Moghaddam B., Adams B., Verma A., and Daly D. (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17, 2921–2927.
  PubMed CAS Google Scholar
• Willins D. L., Narayanan S., Wallace L. J., and Uretsky N. J. (1993) The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801. Pharmacol. Biochem. Behav. 46, 881–887.
  PubMed CAS Google Scholar
• Angrist B. M. and Gershon S. (1970) The phenomenology of experimentally induced amphetamine psychosis: preliminary observations. Biol. Psychiatry 2, 95–107.
  PubMed CAS Google Scholar
• Bell D. (1965) Comparison of amphetamine psychosis and schizophrenia. Am. J. Psychiatry 111, 701–707.
  CAS Google Scholar
• White F. J. and Kalivas P. W. (1998) Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 51, 141–153.
  PubMed CAS Google Scholar
• Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379, 606–612.
  PubMed CAS Google Scholar
• Heikkila R. E., Orlansky H., and Cohen G. (1975) Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem. Pharmacol. 24, 847–852.
  PubMed CAS Google Scholar
• Zhuang X., Oosting R. S., Jones S. R., Gainetdinov R. R., Miller G. W., Caron M. G., and Hen R. (2001) Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proc. Natl. Acad. Sci. USA 98, 1982–1987.
  PubMed CAS Google Scholar
• Uhl G. R., Vandenbergh D. J., and Miner L. L. (1996) Knockout mice and dirty drugs. Drug addiction. Curr. Biol. 6, 935–936.
  PubMed CAS Google Scholar
• Creese I. and Iversen S. D. (1973) Blockage of amphetamine induced motor stimulation and stereotypy in the adult rat following neonatal treatment with 6-hydroxydopamine. Brain Res. 55, 369–382.
  PubMed CAS Google Scholar
• Creese I. and Iversen S. D. (1972) Amphetamine response in rat after dopamine neurone destruction. Nat. New Biol. 238, 247–248.
  PubMed CAS Google Scholar
• Laruelle M., Abi-Dargham A., Gil R., Kegeles L., and Innis R. (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol. Psychiatry 46, 56–72.
  PubMed CAS Google Scholar
• Abi-Dargham A., Gil R., Krystal J., Baldwin R. M., Seibyl J. P., Bowers M., et al. (1998) Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am. J. Psychiatry 155, 761–767.
  PubMed CAS Google Scholar
• Breier A., Su T. P., Saunders R., Carson R. E., Kolachana B. S., de Bartolomeis A., et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. USA 94, 2569–2574.
  PubMed CAS Google Scholar
• Duncan G. E., Sheitman B. B., and Lieberman J. A. (1999) An integrated view of pathophysiological models of schizophrenia. Brain Res. Brain Res. Rev. 29, 250–264.
  PubMed CAS Google Scholar
• Creese I., Burt D. R., and Synder S. H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192, 481–483.
  PubMed CAS Google Scholar
• Rowley M., Bristow L. J., and Hutson P. H. (2001) Current and novel approaches to the drug treatment of schizophrenia. J. Med. Chem. 44, 477–501.
  PubMed CAS Google Scholar
• Jackson D. M., Johansson C., Lindgren L. M., and Bengtsson A. (1994) Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacol. Biochem. Behav. 48, 465–471.
  PubMed CAS Google Scholar
• Ogren S. O. and Goldstein M. (1994) Phencyclidine- and dizocilpine-induced hyperlocomotion are differentially mediated. Neuropsychopharmacology 11, 167–177.
  PubMed CAS Google Scholar
• Castellani S. and Adams P. M. (1981) Effects of dopaminergic drugs on phencyclidine-induced behavior in the rat. Neuropharmacology 20, 371–374.
  PubMed CAS Google Scholar
• Farber N. B., Foster J., Duhan N. L., and Olney J. W. (1996) Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity. Schizophr. Res. 21, 33–37.
  PubMed CAS Google Scholar
• Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain. J. Neurosci. 4, 84–98.
  PubMed CAS Google Scholar
• Langley K. C., Bergson C., Greengard P., and Ouimet C. C. (1997) Co-localization of the D1 dopamine receptor in a subset of DARPP-32-containing neurons in rat caudate-putamen. Neuroscience 78, 977–983.
  PubMed CAS Google Scholar
• Ouimet C. C., Langley-Gullion K. C., and Greengard P. (1998) Quantitative immunocytochemistry of DARPP-32-expressing neurons in the rat caudatoputamen. Brain Res. 808, 8–12.
  PubMed CAS Google Scholar
• Snyder G. L., Allen P. B., Fienberg A. A., Valle C. G., Huganir R. L., Nairn A. C., and Greengard P. (2000) Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J. Neurosci. 20, 4480–4488.
  PubMed CAS Google Scholar
• Snyder G. L., Fienberg A. A., Huganir R. L., and Greengard P. (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J. Neurosci. 18, 10297–10303.
  PubMed CAS Google Scholar
• Fienberg A. A. and Greengard P. (2000) The DARPP-32 knockout mouse. Brain Res. Brain Res. Rev. 31, 313–319.
  PubMed CAS Google Scholar
• Larson J., Quach C. N., LeDuc B. Q., Nguyen A., Rogers G. A., and Lynch G. (1996) Effects of an AMPA receptor modulator on methamphetamine-induced hyperactivity in rats. Brain Res. 738, 353–356.
  PubMed CAS Google Scholar
• Johnson S. A., Luu N. T., Herbst T. A., Knapp R., Lutz D., Arai A., et al. (1999) Synergistic interactions between ampakines and antipsychotic drugs. J. Pharmacol. Exp. Ther. 289, 392–397.
  PubMed CAS Google Scholar
• Farber N. B., Newcomer J. W., and Olney J. W. (1999) Glycine agonists: what can they teach us about schizophrenia? Arch. Gen. Psychiatry 56, 13–17.
  PubMed CAS Google Scholar
• Goff D. C., Tsai G., Manoach D. S., and Coyle J. T. (1995) Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am. J. Psychiatry 152, 1213–1215.
  PubMed CAS Google Scholar
• van Berckel B. N., Hijman R., van der Linden J. A., Westenberg H. G., van Ree J. M., and Kahn R. S. (1996) Efficacy and tolerance of D-cycloserine in drug-free schizophrenic patients. Biol. Psychiatry 40, 1298–1300.
  PubMed Google Scholar
• Goff D. C., Tsai G., Manoach D. S., Flood J., Darby D. G., and Coyle J. T. (1996) D-cycloserine added to clozapine for patients with schizophrenia. Am. J. Psychiatry 153, 1628–1630.
  PubMed CAS Google Scholar
• Goff D. C., Tsai G., Levitt J., Amico E., Manoach D., Schoenfeld D. A., et al. (1999) A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch. Gen. Psychiatry 56, 21–27.
  PubMed CAS Google Scholar
• van Berckel B. N., Evenblij C. N., van Loon B. J., Maas M. F., van der Geld M. A., Wynne H. J., et al. (1999) D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double- blind, parallel, placebo-controlled study. Neuropsychopharmacology 21, 203–210.
  PubMed Google Scholar
• Petrie R. X., Reid I. C., and Stewart C. A. (2000) The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review. Pharmacol. Ther. 87, 11–25.
  PubMed CAS Google Scholar
• Sernagor E., Kuhn D., Vyklicky L., Jr., and Mayer M. L. (1989) Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron 2, 1221–1227.
  PubMed CAS Google Scholar
• Kitamura Y., Zhao X. H., Tekei M., Yonemitsu O., and Nomura Y. (1991) Effects of antidepressants on the glutamatergic system in the mouse brain. Neurochem. Int. 19, 247–253.
  CAS Google Scholar
• Lucki I. (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav. Pharmacol. 8, 523–532.
  PubMed CAS Google Scholar
• Steru L., Chermat R., Thierry B., and Simon P. (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85, 367–370.
  PubMed CAS Google Scholar
• Maier S. F. (1984) Learned helplessness and animal models of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 8, 435–446.
  PubMed CAS Google Scholar
• Willner P. (1997) Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology (Berl) 134, 319–329.
  CAS Google Scholar
• Berman R. M., Cappiello A., Anand A., Oren D. A., Heninger G. R., Charney D. S., and Krystal J. H. (2000) Antidepressant effects of ketamine in depressed patients. Biol. Psychiatry 47, 351–354.
  PubMed CAS Google Scholar
• Paladini C. A., Fiorillo C. D., Morikawa H., and Williams J. T. (2001) Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons. Nat. Neurosci. 4, 275–281.
  PubMed CAS Google Scholar
• Linden A., Yu H., Zarrinmay eh H., Wheeler W. J., and Skolnick P. (2001) Binding of an AMPA receptor potentiator. Neuropharmacology 40, 1010–1018.
  PubMed CAS Google Scholar
• Legutko B., Li X., and Skolnick P. (2001) Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator. Neuropharmacology 40, 1019–1027.
  PubMed CAS Google Scholar
• Siuciak J. A., Lewis D. R., Wiegand S. J., and Lindsay R. M. (1997) Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56, 131–137.
  PubMed CAS Google Scholar
• Altar C. A. (1999) Neurotrophins and depression. Trends Pharmacol. Sci. 20, 59–61.
  PubMed CAS Google Scholar
• Tatarczynska E., Klodzinska A., Chojnacka-Wojcik E., Palucha A., Gasparini F., Kuhn R., and Pilc A. (2001) Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist. Br. J. Pharmacol. 132, 1423–1430.
  PubMed CAS Google Scholar
• Gasparini F., Lingenhohl K., Stoehr N., Flor P. J., Heinrich M., Vranesic I., et al. (1999) 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacology 38, 1493–1503.
  PubMed CAS Google Scholar
• Soares J. C. and Gershon S. (1998) The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 19, 167–182.
  PubMed CAS Google Scholar
• Karkanias N. B. and Papke R. L. (1999) Lithium modulates desensitization of the glutamate receptor subtype gluR3 in Xenopus occytes. Neurosci. Lett. 277, 153–156.
  PubMed CAS Google Scholar
• Karkanias N. B. and Papke R. L. (1999) Subtype-specific effects of lithium on glutamate receptor function. J. Neurophysiol. 81, 1506–1512.
  PubMed CAS Google Scholar
• Phiel C. J. and Klein P. S. (2001) Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol. 41, 789–813.
  PubMed CAS Google Scholar
• Detera-Wadleigh S. D. (2001) Lithium-related genetics of bipolar disorder. Ann. Med. 33, 272–285.
  PubMed CAS Google Scholar
• Dixon A. K., Huber C., and Lowe D. A. (1994) Clozapine promotes approach-oriented behavior in male mice. J. Clin. Psychiatry 55(Suppl B), 4–7.
  PubMed Google Scholar
• Sakimura K., Kutsuwada T., Ito I., Manabe T., Takayama C., Kushiya E., et al. (1995) Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit. Nature 373, 151–155.
  PubMed CAS Google Scholar
• Forrest D., Yuzaki M., Soares H. D., Ng L., Luk D. C., Sheng M., et al. (1994) Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death. Neuron 13, 325–338.
  PubMed CAS Google Scholar
• Li Y., Erzurumlu R. S., Chen C., Jhaveri S., and Tonegawa S. (1994) Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell 76, 427–437.
  PubMed CAS Google Scholar
• Ebralidze A. K., Rossi D. J., Tonegawa S., and Slater N. T. (1996) Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene. J. Neurosci. 16, 5014–5025.
  PubMed CAS Google Scholar
• Kutsuwada T., Sakimura K., Manabe T., Takayama C., Katakura N., Kushiya E., et al. (1996) Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. Neuron 16, 333–344.
  PubMed CAS Google Scholar
• Das S., Sasaki Y. F., Rothe T., Premkumar L. S., Takasu M., Crandall J. E., et al. (1998) Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature 393, 377–381.
  PubMed CAS Google Scholar
• Sprengel R. and Single F. N. (1999) Mice with genetically modified NMDA and AMPA receptors. Ann. NY Acad. Sci. 868, 494–501.
  PubMed CAS Google Scholar
• Aiba A., Kano M., Chen C., Stanton M. E., Fox G. D., Herrup K., et al. (1994) Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell 79, 377–388.
  PubMed CAS Google Scholar
• Masu M., Iwakabe H., Tagawa Y., Miyoshi T., Yamashita M., Fukuda Y., et al. (1995) Specific deficit of the ON response in visual transmission by targeted disruption of the mGluR6 gene. Cell 80, 757–765.
  PubMed CAS Google Scholar
• Pekhletski R., Gerlai R., Overstreet L. S., Huang X. P., Agopyan N., Slater N. T., et al. (1996) Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J. Neurosci. 16, 6364–6373.
  PubMed CAS Google Scholar
• Jia Z., Agopyan N., Miu P., Xiong Z., Henderson J., Gerlai R., et al. (1996) Enhanced LTP in mice deficient in the AMPA receptor GluR2. Neuron 17, 945–956.
  PubMed CAS Google Scholar
• Lu Y. M., Jia Z., Janus C., Henderson J. T., Gerlai R., Wojtowicz J. M., and Roder J. C. (1997) Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J. Neurosci. 17, 5196–5205.
  PubMed CAS Google Scholar
• Mulle C., Sailer A., Perez-Otano I., Dickinson-Anson H., Castillo P. E., Bureau I., et al. (1998) Altered synaptic physiology and reduced susceptibility to kainate-induced seizures in GluR6-deficient mice. Nature 392, 601–605.
  PubMed CAS Google Scholar
• Zamanillo D., Sprengel R., Hvalby O., Jensen V., Burnashev N., Rozov A., et al. (1999) Importance of AMPA receptors for hippocampal synaptic plasticity but not for spatial learning. Science 284, 1805–1811.
  PubMed CAS Google Scholar
• Contractor A., Swanson G. T., Sailer A., O’Gorman S., and Heinemann S. F. (2000) Identification of the kainate receptor subunits underlying modulation of excitatory synaptic transmission in the CA3 region of the hippocampus. J. Neurosci. 20, 8269–8278.
  PubMed CAS Google Scholar
• Huettner J. E. (2001) Kainate receptors: knocking out plasticity. Trends Neurosci. 24, 365–366.
  PubMed CAS Google Scholar
• Paarmann I., Frermann D., Keller B. U., and Hollmann M. (2000) Expression of 15 glutamate receptor subunits and various splice variants in tissue slices and single neurons of brainstem nuclei and potential functional implications. J. Neurochem. 74, 1335–1345.
  PubMed CAS Google Scholar
• Meador-Woodruff J. H. and Healy D. J. (2000) Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 31, 288–294.
  PubMed CAS Google Scholar
• Ibrahim H. M., Healy D. J., Hogg A. J., Jr., and Meador-Woodruff J. H. (2000) Nucleus-specific expression of ionotropic glutamate receptor subunit mRNAs and binding sites in primate thalamus. Brain Res. Mol. Brain Res. 79, 1–17.
  PubMed CAS Google Scholar
• Porter R. H., Eastwood S. L., and Harrison P. J. (1997) Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia. Brain Res. 751, 217–231.
  PubMed CAS Google Scholar
• Sokolov B. P. (1998) Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of “neuroleptic-free” schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J. Neurochem. 71, 2454–2464.
  PubMed CAS Google Scholar
• Ibrahim H. M., Hogg A. J., Jr., Healy D. J., Haroutunian V., Davis K. L., and Meador-Woodruff J. H. (2000) Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. Am. J. Psychiatry 157, 1811–1823.
  PubMed CAS Google Scholar
• Akbarian S., Sucher N. J., Bradley D., Tafazzoli A., Trinh D., Hetrick W. P., et al. (1996) Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16, 19–30.
  PubMed CAS Google Scholar
• Ohnuma T., Augood S. J., Arai H., McKenna P. J., and Emson P. C. (1998) Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res. Mol. Brain Res. 56, 207–217.
  PubMed CAS Google Scholar
• Boyer P. A., Skolnick P., and Fossom L. H. (1998) Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study. J. Mol. Neurosci. 10, 219–233.
  PubMed CAS Google Scholar
• Nowak G., Ordway G. A., and Paul I. A. (1995) Alterations in the N-methyl-D-aspartate (NMDA) receptor complex in the frontal cortex of suicide victims. Brain Res. 675, 157–164.
  PubMed CAS Google Scholar
• Palmer A. M., Burns M. A., Arango V., and Mann J. J. (1994) Similar effects of glycine, zinc and an oxidizing agent on [3H]dizocilpine binding to the N-methyl-D-aspartate receptor in neocortical tissue from suicide victims and controls. J. Neural. Transm. Gen. Sect. 96, 1–8.
  PubMed CAS Google Scholar
• Karlsson H., Bachmann S., Schroder J., McArthur J., Torrey E. F., and Yolken R. H. (2001) Retroviral RNA identified in the cere-brosprnal fluids and brains of individuals with schizophrenia. Proc. Natl. Acad. Sci. USA 98, 4634–4639.
  PubMed CAS Google Scholar
• Coyle J. T. (1996) The glutamatergic dysfunction hypothesis for schizophrenia. Harv. Rev. Psychiatry 3, 241–253.
  PubMed CAS Google Scholar
• Ohtsuki T., Sakurai K., Dou H., Toru M., Yamakawa-Kobayashi K., and Arinami T. (2001) Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol. Psychiatry 6, 211–216.
  PubMed CAS Google Scholar
• Rice S. R., Niu N., Berman D. B., Heston L. L., and Sobell J. L. (2001) Identification of single nucleotide polymorphisms (SNPs) and other sequence changes and estimation of nucleotide diversity in coding and flanking regions of the NMDAR1 receptor gene in schizophrenic patients. Mol. Psychiatry 6, 274–284.
  PubMed CAS Google Scholar
• Nishiguchi N., Shirakawa O., Ono H., Hashimoto T., and Maeda K. (2000) Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am. J. Psychiatry 157, 1329–1331.
  PubMed CAS Google Scholar
• Sakurai K., Toru M., Yamakawa-Kobayashi K., and Arinami T. (2000) Mutation analysis of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) in schizophrenia. Neurosci. Lett. 296, 168–170.
  PubMed CAS Google Scholar
• Fitzjohn S. M., Irving A. J., Palmer M. J., Harvey J., Lodge D., and Collingridge G. L. (1996) Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices. Neurosci. Lett. 203, 211–213.
  PubMed CAS Google Scholar
• Bolonna A. A., Kerwin R. W., Munro J., Arranz M. J., and Makoff A. J. (2001) Polymorphisms in the genes for mGluR types 7 and 8: association studies with schizophrenia. Schizophr. Res. 47, 99–103.
  PubMed CAS Google Scholar
• Devon R. S., Anderson S., Teague P. W., Muir W. J., Murray V., Pelosi A. J., et al. (2001) The genomic organisation of the metabotropic glutamate receptor subtype 5 gene, and its association with schizophrenia. Mol. Psychiatry 6, 311–314.
  PubMed CAS Google Scholar
• Joo A., Shibata H., Ninomiya H., Kawasaki H., Tashiro N., and Fukumaki Y. (2001) Structure and polymorphisms of the human metabotropic glutamate receptor type 2 gene (GRM2): analysis of association with schizophrenia. Mol. Psychiatry, 6, 186–192.
  PubMed CAS Google Scholar
• Muir W. J., Gosden C. M., Brookes A. J., Fantes J., Evans K. L., Maguire S. M., et al. (1995) Direct microdissection and microcloning of a translocation breakpoint region, t(1;11)(q42.2;q21), associated with schizophrenia. Cytogenet. Cell Genet. 70, 35–40.
  PubMed CAS Google Scholar
• Fletcher J. M., Evans K., Baillie D., Byrd P., Hanratty D., Leach S., et al. (1993) Schizophrenia-associated chromosome 11q21 translocation: identification of flanking markers and development of chromosome 11q fragment hybrids as cloning and mapping resources. Am. J. Hum. Genet. 52, 478–490.
  PubMed CAS Google Scholar
• Semple C. A., Devon R. S., Le Hellard S., and Porteous D. J. (2001) Identification of genes from a schizophrenia-linked translocation breakpoint region. Genomics 73, 123–126.
  PubMed CAS Google Scholar
• Alagarsamy S., Marino M. J., Rouse S. T., Gereau R. W. T., Heinemann S. F., and Conn P. J. (1999) Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems. Nat. Neurosci. 2, 234–240.
  PubMed CAS Google Scholar
• Neale J. H., Bzdega T., and Wroblewska B. (2000) N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system. J. Neurochem. 75, 443–452.
  PubMed CAS Google Scholar
• Tsai G., Passani L. A., Slusher B. S., Carter R., Baer L., Kleinman J. E., and Coyle J. T. (1995) Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. Arch. Gen. Psychiatry 52, 829–836.
  PubMed CAS Google Scholar
• Chen A. C., Kalsi G., Brynjolfsson J., Sigmundsson T., Curtis D., Butler R., et al. (1997) Exclusion of linkage of schizophrenia to the gene for the glutamate GluR5 receptor. Biol. Psychiatry 41, 243–245.
  PubMed CAS Google Scholar
• Chen A. C., Kalsi G., Brynjolfsson J., Sigmundsson T., Curtis D., Butler R., et al. (1996) Lack of evidence for close linkage of the glutamate GluR6 receptor gene with schizophrenia. Am. J. Psychiatry 153, 1634–1636.
  PubMed CAS Google Scholar
• Noga J. T., Hyde T. M., Herman M. M., Spurney C. F., Bigelow L. B., Weinberger D. R., and Kleinman J. E. (1997) Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 27, 168–176.
  PubMed CAS Google Scholar
• Freed W. J., Dillon-Carter O., and Kleinman J. E. (1993) Properties of [3H]AMPA binding in postmortem human brain from psychotic subjects and controls: increases in caudate nucleus associated with suicide. Exp. Neurol. 121, 48–56.
  PubMed CAS Google Scholar
• Gecz J., Barnett S., Liu J., Hollway G., Donnelly A., Eyre H., et al. (1999) Characterization of the human glutamate receptor subunit 3 gene (GRIA3), a candidate for bipolar disorder and nonspecific X-linked mental retardation. Genomics 62, 356–368.
  PubMed CAS Google Scholar
• Rice J. P., Saccone N. L., and Rasmussen E. (2001) Definition of the phenotype. Adv. Genet. 42, 69–76.
  PubMed CAS Google Scholar
• Sachidanandam R., Weissman D., Schmidt S. C., Kakol J. M., Stein L. D., Marth G., et al. (2001) A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 409, 928–933.
  PubMed CAS Google Scholar
• Baron M. (2001) Genetics of schizophrenia and the new millennium: progress and pitfalls. Am. J. Hum. Genet. 68, 299–312.
  PubMed CAS Google Scholar
• Thaker G. K. and Carpenter W. T., Jr. (2001) Advances in schizophrenia. Nat. Med. 7, 667–671.
  PubMed CAS Google Scholar
• Kato T. (2001) Molecular genetics of bipolar disorder. Neurosci. Res. 40, 105–113.
  PubMed CAS Google Scholar
• Todd R. D. and Botteron K. N. (2001) Family, genetic, and imaging studies of early-onset depression. Child. Adolesc. Psychiatr Clin. North Am. 10, 375–390.
  CAS Google Scholar
• Kornberg J. R., Brown J. L., Sadovnick A. D., Remick R. A., Keck P. E., Jr., McElroy S. L., et al. (2000) Evaluating the parent-of-origin effect in bipolar affective disorder. Is a more penetrant subtype transmitted paternally? J. Affect. Disord. 59, 183–192.
  PubMed CAS Google Scholar
• Ohara K. (2001) Anticipation, imprinting, trinucleotide repeat expansions and psychoses. Prog. Neuropsychopharmacol. Biol. Psychiatry 25, 167–192.
  PubMed CAS Google Scholar
• Keverne E. B. (1997) Genomic imprinting in the brain. Curr. Opin. Neurobiol. 7, 463–468.
  PubMed CAS Google Scholar
• Reik W. and Walter J. (2001) Genomic imprinting: parental influence on the genome. Nat. Rev. Genet. 2, 21–32.
  PubMed CAS Google Scholar
• Latham K. E. (1999) Epigenetic modification and imprinting of the mammalian genome during development. Curr. Top. Dev. Biol. 43, 1–49.
  PubMed CAS Google Scholar
• Nadeau J. H. (2001) Modifier genes in mice and humans. Nat. Rev. Genet. 2, 165–174.
  PubMed CAS Google Scholar
• Falls J. G., Pulford D. J., Wylie A. A., and Jirtle R. L. (1999) Genomic imprinting: implications for human disease. Am. J. Pathol. 154, 635–647.
  PubMed CAS Google Scholar
• Morison I. M., Paton C. J., and Cleverley S. D. (2001) The imprinted gene and parent-of-origin effect database. Nucleic Acids Res. 29, 275–276.
  PubMed CAS Google Scholar
• Constancia M., Pickard B., Kelsey G., and Reik W. (1998) Imprinting mechanisms. Genome Res. 8, 881–900.
  PubMed CAS Google Scholar
• Mowry B. J. and Nancarrow D. J. (2001) Molecular genetics of schizophrenia. Clin. Exp. Pharmacol. Physiol. 28, 66–69.
  PubMed CAS Google Scholar
• Warrington J. A., Bailey S. K., Armstrong E., Aprelikova O., Alitalo K., Dolganov G. M., et al. (1992) A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor, or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5. Genomics 13, 803–808.
  PubMed CAS Google Scholar
• Puckett C., Gomez C. M., Korenberg J. R., Tung H., Meier T. J., Chen X. N., and Hood L. (1991) Molecular cloning and chromosomal localization of one of the human glutamate receptor genes. Proc. Natl. Acad. Sci. USA 88, 7557–7561.
  PubMed CAS Google Scholar
• Sun W., Ferrer-Montiel A. V., Schinder A. F., McPherson J. P., Evans G. A., and Montal M. (1992) Molecular cloning, chromosomal mapping, and functional expression of human brain glutamate receptors. Proc. Natl. Acad. Sci. USA 89, 1443–1447.
  PubMed CAS Google Scholar
• McNamara J. O., Eubanks J. H., McPherson J. D., Wasmuth J. J., Evans G. A., and Heinemann S. F. (1992) Chromosomal localization of human glutamate receptor genes. J. Neurosci. 12, 2552–2562.
  Google Scholar
• Hu W., Zuo J., De Jager P. L., and Heintz N. (1998) The human glutamate receptor delta 2 gene (GRID2) maps to chromosome 4q22. Genomics 47, 143–145.
  PubMed CAS Google Scholar
• Gregor P., Gaston S. M., Yang X., O’Regan J. P., Rosen D. R., Tanzi R. E., et al. (1994) Genetic and physical mapping of the GLUR5 glutamate receptor gene on human chromosome 21. Hum. Genet. 94, 565–570.
  PubMed CAS Google Scholar
• Eubanks J. H., Puranam R. S., Kleckner N. W., Bettler B., Heinemann S. F., and McNamara J. O. (1993) The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1–22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 90, 178–182.
  PubMed CAS Google Scholar
• Sander T., Janz D., Ramel C., Ross C. A., Paschen W., Hildmann T., et al. (1995) Refinement of map position of the human GluR6 kainate receptor gene (GRIK2) and lack of association and linkage with idiopathic generalized epilepsies. Neurology 45, 1713–1720.
  PubMed CAS Google Scholar
• Paschen W., Blackstone C. D., Huganir R. L., and Ross C. A. (1994) Human GluR6 kainate receptor (GRIK2): molecular cloning, expression, polymorphism, and chromosomal assignment. Genomics 20, 435–440.
  PubMed CAS Google Scholar
• Puranam R. S., Eubanks J. H., Heinemann S. F., and McNamara J. O. (1993) Chromosomal localization of gene for human glutamate receptor subunit-7. Somat. Cell Mol. Genet. 19, 581–588.
  PubMed CAS Google Scholar
• Szpirer C., Molne M., Antonacci R., Jenkins N. A., Finelli P., Szpirer J., et al. (1994) The genes encoding the glutamate receptor subunits KA1 and KA2 (GRIK4 and GRIK5) are located on separate chromosomes in human, mouse, and rat. Proc. Natl. Acad. Sci. USA 91, 11849–11853.
  PubMed CAS Google Scholar
• Brett P. M., Le Bourdelles B., See C. G., Whiting P. J., Attwood J., Woodward K., et al. (1994) Genomic cloning and localization by FISH and linkage analysis of the human gene encoding the primary subunit NMDAR1 (GRIN1) of the NMDA receptor channel. Ann. Hum. Genet. 58, 95–100.
  PubMed CAS Google Scholar
• Karp S. J., Masu M., Eki T., Ozawa K., and Nakanishi S. (1993) Molecular cloning and chromosomal localization of the key subunit of the human N-methyl-D-aspartate receptor. J. Biol. Chem. 268, 3728–3733.
  PubMed CAS Google Scholar
• Collins C., Duff C., Duncan A. M., Planells-Cases R., Sun W., Norremolle A., et al. (1993) Mapping of the human NMDA receptor subunit (NMDAR1) and the proposed NMDA receptor glutamate-binding subunit (NMDARA1) to chromosomes 9q34.3 and chromosome 8, respectively. Genomics 17, 237–239.
  PubMed CAS Google Scholar
• Takano H., Onodera O., Tanaka H., Mori H., Sakimura K., Hori T., et al. (1993) Chromosomal localization of the epsilon 1, epsilon 3 and zeta 1 subunit genes of the human NMDA receptor channel. Biochem. Biophys. Res. Commun. 197, 922–926.
  PubMed CAS Google Scholar
• Kalsi G., Whiting P., Bourdelles B. L., Callen D., Barnard E. A., and Gurling H. (1998) Localization of the human NMDAR2D receptor subunit gene (GRIN2D) to 19q13.1-qter, the NMDAR2A subunit gene to 16p13.2 (GRIN2A), and the NMDAR2C subunit gene (GRIN2C) to 17q24-q25 using somatic cell hybrid and radiation hybrid mapping panels. Genomics 47, 423–425.
  PubMed CAS Google Scholar
• Mandich P., Schito A. M., Bellone E., Antonacci R., Finelli P., Rocchi M., and Ajmar F. (1994) Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12. Genomics 22, 216–218.
  PubMed CAS Google Scholar
• Stephan D., Bon C., Holzwarth J. A., Galvan M., and Pruss R. M. (1996) Human metabotropic glutamate receptor 1: mRNA distribution, chromosome localization and functional expression of two splice variants. Neuropharmacology 35, 1649–1660.
  PubMed CAS Google Scholar
• Ganesh S., Amano K., and Yamakawa K. (2000) Assignment of the gene GRM1 coding for metabotropic glutamate receptor 1 to human chromosome band 6q24 by in situ hybridization. Cytogenet. Cell Genet. 88, 314–315.
  PubMed CAS Google Scholar
• Flor P. J., Lindauer K., Puttner I., Ruegg D., Lukic S., Knopfel T., and Kuhn R. (1995) Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2. Eur. J. Neurosci. 7, 622–629.
  PubMed CAS Google Scholar
• Scherer S. W., Duvoisin R. M., Kuhn R., Heng H. H., Belloni E., and Tsui L. C. (1996) Localization of two metabotropic glutamate receptor genes, GRM3 and GRM8, to human chromosome 7q. Genomics 31, 230–233.
  PubMed CAS Google Scholar
• Barbon A., Ferraboli S., and Barlati S. (2000) Assignment of the human metabotropic glutamate receptor gene GRM4 to chromosome 6 band p21.3 by radiation hybrid mapping. Cytogenet. Cell Genet. 88, 210.
  PubMed CAS Google Scholar
• Devon R. S. and Porteous D. J. (1997) Physical mapping of a glutamate receptor gene in relation to a balanced translocation associated with schizophrenia in a large Scottish family. Psychiatr. Genet. 7, 165–169.
  PubMed CAS Google Scholar
• Hashimoto T., Inazawa J., Okamoto N., Tagawa Y., Bessho Y., Honda Y., and Nakanishi S. (1997) The whole nucleotide sequence and chromosomal localization of the gene for human metabotropic glutamate receptor subtype 6. Eur. J. Neurosci. 9, 1226–1235.
  PubMed CAS Google Scholar
• Barbon A., Ferraboli S., and Barlati S. (2000) Assignment of the human metabotropic glutamate receptor gene GRM7 to chromosome 3p26.1→p25.2 by radiation hybrid mapping. Cytogenet. Cell Genet. 88, 288.
  PubMed CAS Google Scholar